JPRN-jRCTs061180065招募中未知
The investigation of the effectiveness by tofogliflozin on macular edema among the Japanese patients with type 2 diabetes mellitus - Ehime Macular Edema Study
Shiraishi Atsushi0 个研究点目标入组 30 人开始时间: 2019年3月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •Patients with diabetic macular edema
- •Patients with a CRT of 250 micro m or more in OCT
- •Patients with corrective eyesight of 0.1 or more
- •Patients with diabetic retinopathy (simple, pre proliferative)
- •Patients who have not undergone other treatments for macular edema (anti-VEGF drug, steroid local injection, retinal photocoagulation, intraocular surgery) within 3 months until acquisition
排除标准
- •Patients with diabetic macular edema who need and wish anti-VEGF medication
- •Patients with diabetic macular edema who need and wish subtenon Tenon's administration of MaQaid OPHTALMIC INJECTION 20 mg (triamcinolone acetonide) medication
- •Patients with diabetic retinopathy who need Panretinal photocoagulation
- •Patients with obvious vitreous traction at OCT
研究者
相似试验
招募中
不适用
The investigation of the effectiveness by tofogliflozin on macular edema among the Japanese patients with type 2 diabetes mellitusMacular edemaJPRN-UMIN000029609Ehime University30
招募中
不适用
STRIDE Study to evaluate the effect of Tofogliflozin on VRH In T2DM using ECGType2 diabetes mellitus with obesity and high blood pressureJPRN-UMIN000043061Sapporo Medical University100
已完成
不适用
Study to evaluate the effectiveness and saftyof the mFOLFOX+bevacizumab combination therapy for bladder adenocarcinomabladder adenocarcinomaJPRN-UMIN000021193agoya City University Hospital2
招募中
Unknown
Quitting Using Incentives Trial for a HEaLthy Pregnancy (QUIT-HELP)ACTRN12623000922673niversity of Adelaide460
已完成
不适用
The examination of effects of adding on Tofogliflozin or not to add for type 2 diabetes controlled insufficiently by long-acting insulin glargine once daily with DPP-4 inhibitor or GLP-1 analog liraglutide with oral anti-diabetic agents (multicenter study)JPRN-UMIN000016969Toho University School of Medicine, Division of diabetes, metabolism and endocrinology15